337,445 persons vaccinated against COVID-19 on Tuesday

Thursday, 15 July 2021 01:48 -     - {{hitsCtrl.values.hits}}

Over 300,000 persons received either the first or second dose of a COVID-19 vaccine on Tuesday, the highest number of persons vaccinated in a day since the country’s COVID-19 immunisation program was launched in January.

In total, 4,520,537 persons in the country have received the first dose of a vaccine and 1,537,230 persons have received the second dose of a COVID-19 vaccine. At present, the Sinopharm, Sputnik V, Pfizer and AstraZeneca vaccines are being administered in the country.

According to the Epidemiology Unit, the highest number of vaccines administered was the Sinopharm COVID-19 vaccine, with 289,122 persons receiving the first dose and 32,385 persons receiving the second dose of the vaccine on Tuesday. In total, 3,417,525 persons have received the first dose of Sinopharm and 1,136,881 persons have received the second dose of the vaccine.

On Tuesday, 15,202 persons received the Sputnik V first dose, raising the number of persons to receive the first dose of the vaccine to 154,003. The second dose of Sputnik V has been administered to 14,464 persons.

The Epidemiology Unit states that 700 persons received the first dose of Pfizer on Tuesday and a total of 23,767 persons have received the Pfizer first dose in the country.

In addition to this, the second dose of the AstraZeneca COVID-19 vaccine was administered to 36 persons on Tuesday. In total, 925,242 persons have received the AstraZeneca first dose and 385,885 persons have received the AstraZeneca second dose.

Meanwhile, the Sri Lanka Army stated that a vaccination centre will operate at the Open-Air Theatre at the Viharamahadevi Park starting today. The centre will be operated by the Sri Lanka Army between 8.30 a.m. and 4.30 p.m. until further notice.

Western Province residents are eligible to receive the COVID-19 vaccine at the centre.

 

1,540 persons test positive for COVID-19

37 COVID-19 deaths raise fatalities to 3,611

COMMENTS